Capricor Therapeutics (NASDAQ: CAPR) announced the selection of Karimah Es Sabar to its Panel of Directors, actually instantly.  Sahar is a recognized front-runner Es Sabar is an extremely considered and recognized front-runner in life disciplines business and carries over 35 years of worldwide corporate administration involvement to Capricor. “I am […]